Magenta Therapeutics, Inc(NASDAQ:MGTA) 
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant condi...
Website: http://www.magentatx.com
Founded: 2015
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-14
P
O 0.79
H 0.79
L 0.74
C 0.75
V 310,646
10EMA 0.75
20EMA 0.75
60EMA 0.75
120EMA 0.75
250EMA 0.75